25520-73-4

Basic information

• Product Name: (S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid
• Synonyms: (S)-2-Amino-3-(3,4-dihydro-3,4-dioxobenzene-1-yl)propionic acid;(S)-3-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-2-aminopropionic acid;(S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid;L-Dopaquinone;Dopaquinone Sulphate;Dopaquinone Sulphate Discontinued
• CAS NO: 25520-73-4
• Molecular Formula: C₉H₉NO₄
• Molecular Weight: 195.17
• Product Categories: Amines, Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 25520-73-4.mol
• Article Data: 37

Chemical Properties

• Boiling Point: 419.5±45.0 °C(Predicted)
• Appearance: /
• Density: 1.426±0.06 g/cm3(Predicted)
• PKA: 2.18±0.10(Predicted)
• CAS DataBase Reference: (S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid(25520-73-4)
• EPA Substance Registry System: (S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid(25520-73-4)

Safety Data

• Hazardous Substances Data: 25520-73-4(Hazardous Substances Data)

Usage

Description

(S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid, also known as Dopaquinone, is an L-phenylalanine derivative in which the hydroxyphenyl group of L-phenylalanine is replaced by a 3,4-dioxocyclohexa-1,5-dien-1-yl group. It is a significant intermediate in the biogenesis of tyrosine-derived quinone cofactors, playing a crucial role in various biochemical processes.

Uses

Used in Pharmaceutical Industry:
(S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid is used as an intermediate for the synthesis of tyrosine-derived quinone cofactors, which are essential components in various pharmaceutical applications. These cofactors are involved in numerous biological processes, making them important targets for drug development.
Used in Chemical Synthesis:
In the field of chemical synthesis, (S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid serves as a key building block for the creation of various complex organic molecules. Its unique structure allows for further functionalization and modification, leading to the development of novel compounds with potential applications in various industries.
Used in Research and Development:
(S)-α-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid is also utilized in research and development, particularly in the study of tyrosine-derived quinone cofactors and their role in biological systems. Understanding the properties and reactivity of this compound can contribute to the advancement of scientific knowledge and the discovery of new therapeutic agents.

Upstream product

• 60-18-4 L-tyrosine 
• 300-48-1 3-O-methyldopa 
• 59-92-7 levodopa 

Downstream Products

• 55136-58-8 5-S-G-L-D 
• 19641-92-0 3-<(R)-2-amino-2-carboxyethylthio>-5-<(S)-2-amino-2-carboxyethyl>-1,2-dihydroxybenzene 
• 59-92-7 levodopa 
• 18766-67-1 leucodopachromene 

Relevant articles and documents

Protection of mesopore-adsorbed organic matter from enzymatic degradation

Synthetic mesoporous alumina and silica minerals with uniform pore geometries, and their nonporous analogues, were used to test the role of mineral mesopores (2-50 nm diameter) in protecting organic matter from enzymatic degradation in soils and sediments

Enantioselectively catalyzed oxidation of 3,4-dihydroxy-L-phenylalanine by N-lauroyl L or D-histidine-Cu(II) complex in CTABr micelles

-

Highly sensitive voltammetric sensor based on NiO nanoparticle room temperature ionic liquid modified carbon paste electrode for levodopa analysis

This paper describes the development of 1-methyl-3-butylimidazolium chloride ionic liquid-NiO nanoparticle modified carbon paste electrode (MBICl/NiO/NPs/CPE) for the voltammetric determination of levodopa (l-DOPA) in real samples. We describe the synthes

Reactivity of dinuclear copper(II) complexes towards melanoma cells: Correlation with its stability, tyrosinase mimicking and nuclease activity

In this work, the influence of two new dinuclear copper(II) complexes in the viability of melanoma cells (B16F10 and TM1MNG3) was investigated, with the aim of verifying possible correlations between their cytotoxicity and their structure. One of the comp

Tyrosinase inhibitory polyphenols from roots of Morus Ihou

Twelve polyphenols (1-12) possessing tyrosinase inhibitory properties were isolated from the methanol (95%) extract of Morus Ihou. The isolated compounds consisted of four flavanones (1 -4), four flavones (5-8), and four phenylbenzofuranes (9-12). Moracin derivative 12 proved to be new a compound which was fully characterized. Compounds 1-12 were evaluated for both monophenolase and diphenolase (the two steps catalyzed by tyrosinase) inhibition to identify the structural characteristics required for mushroom tyrosinase inhibition. We observed that all parent compounds (1, 5, and 9) possessing an unsubstituted resorcinol group were highly effective inhibitors of monophenolase activity (IC50 values of 1.3, 1.2, and 7.4 μM). The potency of the inhibitors diminished with alkyl substitution on either the aromatic ring or the hydroxyl functions. Interestingly, flavone 5 was shown to possess only monophenolase inhibitory activity, but flavanone 1 and phenylbenzofuran 9 inhibited diphenolase as well as monophenolase significantly. The inhibitory mode of these species was also dependent upon the skeleton: phenylbenzofuran 9 manifested a simple competitive inhibition mode for monophenolase and diphenolase; on the other hand flavanone 1 (monophenolase, K3 = 0.1966 min-1 μM-1 k4= 0.0082 min ～1, and Kiapp = 0.0468 μM; diphenolase, k3 = 0.0014 min-1 μM-1 k4 = 0.0013 min-1, and Kiapp = 0.8996 μM) and flavone 5 both showed time-dependent inhibition against monophenolase. Compound 1 operated according to the simple reversible slow binding model whereas compound 5 operated under the enzyme isomerization model.

Tyrosinase inactivation in its action on dopa

Under aerobic or anaerobic conditions, tyrosinase undergoes a process of irreversible inactivation induced by its physiological substrate l-dopa. Under aerobic conditions, this inactivation occurs through a process of suicide inactivation involving the fo

Stereoselective Electrone Transfer between Chiral Catecholamines and Iron(III) Complex Ions Anchored to Asymmetric Polymers. A Kinetic and Conformational Investigation

The oxydation of L-dopa (3,4-dihydroxyphenylalanine) and L-adrenaline (epinephrine) by + complex ions anchored to poly(L-glutamate) (FeTL) or poly(D-glutamate) (FeTD) was studied at pH 7 (tetpy = 2,2':6',2'':6'',2'''-tetrapyridy

Coumaric acid derivatives as tyrosinase inhibitors: Efficacy studies through in silico, in vitro and ex vivo approaches

p-Coumaric acid is a known inhibitor of tyrosinase, an enzyme involved in the initial steps of the melanin synthesis in human and other species. However, its low lipophilicity impairs its penetration through skin and efficacy as antimelanogenic agent indeed. Accordingly, this paper reports the assessment of several coumaric acid derivatives as tyrosinase inhibitors and antimelanogenic agents in in vitro, in silico and ex vivo assays. The compounds were designed with modifications in the aromatic and acid moieties of p-coumaric acid, being the coumarate esters the most promising derivatives. The compounds showed higher tyrosinase inhibitory activity (pIC50 3.7–4.2) than the parent acid, being compounds 1d, 1e and 1f the most potent inhibitors. Docking analysis showed that these esters are competitive inhibitors per se, and act independently of a redox mechanism as suggested by DPPH assays. Moreover, the esters showed efficacy in reducing the melanin deposition in human skin fragments at 0.1% concentration, especially compound 1e. In summary, there is an important equilibria between tyrosinase affinity and lipophilicity that must be considered to get effective antimelanogenic agents with adequate permeability in the skin.